Overwhelmed by the Complexity of Options? This May Help

Some Things that You Should Know Regarding Bipolar Depression

You must understand that bipolar disorder is a kind of condition which affects all types of individuals. Children and adults are affected by this condition. Such is a fact that you must understand. Those women would suffer the most from such type of depression which is known as bipolar depression disorder.

This isn’t very strange or far-fetched in any case, since even when the women would suffer from such regular bipolar kind of depression or the depressive disorder, they would often spend more time depressed than they do being manic. This isn’t to say that only the women are depressive, the men also are and they may get affected by such condition.

The bipolar type of disorder is known as manic depression because this is a mental condition wherein you would interchange often between the phases of mania and depression. If you suffer from such bipolar depression, you won’t have to spend a lot of time being manic as you spend getting depressed.

This type of depression is one form of disorder and you should understand that it is really easy to wrongly diagnose as bipolar disorder due to the similarity in their symptoms. Because of such, the doctor must keep you around for such a long time when they would try to diagnose the condition you have. It is definitely not flattering to either of you if you would be treated for a wrong thing.

The bipolar affective disorder is another name for such bipolar disorder or the manic-depressive illness. But, you don’t like to mistake this for bipolar depression disorder. This is closely related with the symptoms of the depressive phase of the bipolar disorder but just a few of the mania.

The monotherapy trials from placebo is actually the gold-standard design in knowing the efficacy when it comes to the treatment of bipolar depression. When the efficacy would be proven as a monotherapy, the new compounds can be tested in such adjunctive-medication placebo-controlled trials. The younger adults, without the need for the long-term medication can be fit for the clinical trials which need placebo-controls. The switch to mania or hypomania can be the consequence of such active treatment for the bipolar depression.

Some medications like the tricyclic antidepressants and the venlafaxine can be more likely to prove switch as compared to the others but the increased rate of the switch can’t be seen until about 10 weeks of treatment. Hence, the 12-week trials against placebo are required to determine such risk of switch and to establish such continuing effects. Know that such careful assessments at six to eight weeks are needed to ensure that the patients who fail to respond don’t continue in the study for such unacceptable periods of time.